Protein Kinase C Involvement in Neuroprotective Effects of Thymol and Carvacrol Against Toxicity Induced by Amyloid-β in Rat Hippocampal Neurons.
Zahra AziziSamira ChoopaniMona SalimiNahid MajlessiNasser NaghdiPublished in: Basic and clinical neuroscience (2022)
Alzheimer's disease is one of the most important brain diseases in which the learning and memory are impaired. One of the main causes of Alzheimer's disease is the presence of amyloid beta plaques in the neurons. Protein kinase C enzyme reduces amyloid production and accumulation in the brain. In the present study, we tested the possible effects of carvacrol and thymol in a rat model of Alzheimer's disease. Memory impairment was induced in adult rats by intra-cerebral infusion of amyloid β. One week later, the memory-impaired animals were treated with carvacrol and thymol. Finally, we tested their memory in a Morris water maze apparatus. Furthermore, their hippocampus was dissected and PKC activity and the neuronal injury was evaluated. Our findings exhibited that thymol and carvacrol improved rats' memory performance. In addition, thymol and carvacrol significantly increased PKC activity and prevented neuronal cell loss in the rat hippocampus. This study shows that thymol and carvacrol have beneficial effects on memory and cognitive function via PKC activation.
Keyphrases
- cerebral ischemia
- protein kinase
- working memory
- subarachnoid hemorrhage
- oxidative stress
- cognitive decline
- spinal cord
- white matter
- resting state
- low dose
- single cell
- brain injury
- randomized controlled trial
- clinical trial
- cell therapy
- spinal cord injury
- high glucose
- endothelial cells
- bone marrow
- diabetic rats
- young adults
- newly diagnosed
- childhood cancer